MedTrace Logo

Contour 3D®/TriAd® Tricuspid Annuloplasty Ring Post-Market Clinical Trial

NCT01585779 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 64

Last updated 2017-05-10

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to gather clinical information on the hemodynamic performance of the Contour 3D® and Tri-Ad® Tricuspid Annuloplasty Rings in a post-market environment.

Conditions

  • Tricuspid Valve Regurgitation
  • Tricuspid Valve Insufficiency

Interventions

DEVICE

Contour 3D® implant for tricuspid valve repair

Tricuspid annuloplasty ring

DEVICE

Tri-Ad® implant for tricuspid valve repair

Tricuspid annuloplasty ring

Sponsors & Collaborators

  • Medtronic Cardiovascular

    lead INDUSTRY

Principal Investigators

  • Eric Vang · Medtronic

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01585779 on ClinicalTrials.gov